Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

In vitro bioequivalence testing.

Shein-Chung Chow1, Jun Shao, Hansheng Wang

  • 1Statplus Inc, Heston Hall, Suite 206, 1790 Yardley-Langhorne Road, Yardley, PA 19067, USA.

Statistics in Medicine
|December 18, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Delphinidin targets voltage-dependent anion channel 1 to inhibit ferroptosis and protect against retinal photochemical damage.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Same author

Genome-wide analysis of the <i>GID</i> gene family in soybean and analysis of expression under gibberellin treatment.

Frontiers in plant science·2026
Same author

Decentralized EM algorithm for Gaussian mixtures under data heterogeneity and partial labeling.

Biometrics·2026
Same author

Efficacy and safety of ultrasound-guided microwave ablation for primary hyperparathyroidism: a dual-centre study.

Scientific reports·2026
Same author

Multiscale multimodal graph convolutional networks for identifying essential tremor and dystonic tremor.

Neurobiology of disease·2026
Same author

Correction: RBX1 regulates PKM alternative splicing to facilitate anaplastic thyroid carcinoma metastasis and aerobic glycolysis by destroying the SMAR1/HDAC6 complex.

Cell & bioscience·2026
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
Same journal

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Statistics in medicine·2026
Same journal

A Mixture of Distributed Lag Non-Linear Models to Account for Spatially Heterogeneous Exposure-Lag-Response Associations.

Statistics in medicine·2026
Same journal

Practical Considerations for Gaussian Process Modeling for Causal Inference in Quasi-Experimental Studies With Panel Data.

Statistics in medicine·2026
Same journal

Covariate Adjustment for Wilcoxon Two Sample Statistic and Test.

Statistics in medicine·2026
See all related articles

A new statistical test enhances in vitro bioequivalence testing for nasal spray and aerosol drug products. This method improves accuracy with replicated data, aiding regulatory compliance and drug development.

Area of Science:

  • Pharmacokinetics and Pharmaceutical Sciences
  • Biostatistics and Statistical Modeling
  • Drug Delivery Systems

Background:

  • In vitro bioequivalence testing is crucial for pharmaceutical product development and regulatory approval.
  • Existing statistical methods, like the FDA 1999 guidance, may not fully accommodate replicated observations from drug product samples.
  • Accurate statistical analysis is essential for demonstrating therapeutic equivalence between different drug formulations.

Purpose of the Study:

  • To propose a generalized statistical test for in vitro bioequivalence assessment of nasal drug products.
  • To extend existing FDA guidance to situations with replicated observations per drug product unit.
  • To provide a statistically robust method for comparing nasal aerosols and sprays.

Main Methods:

Related Experiment Videos

  • Generalization of the FDA 1999 guidance for bioequivalence testing.
  • Application of the Hyslop, Hsuan, and Holder technique for asymptotic accuracy.
  • Simulation studies to evaluate type I error probability and statistical power.
  • Development of a sample size determination method for desired power.

Main Results:

  • The proposed statistical test demonstrates asymptotic accuracy.
  • Simulation results provide insights into the test's performance regarding type I error and power.
  • A practical method for sample size calculation is presented.
  • The generalized test effectively handles replicated observations in bioequivalence studies.

Conclusions:

  • The proposed statistical test offers a more robust approach to in vitro bioequivalence testing for nasal drug products.
  • The method enhances the ability to demonstrate bioequivalence when replicated data are available.
  • This work supports regulatory agencies and pharmaceutical manufacturers in ensuring drug product quality and equivalence.